| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$500 ) |
| | 2024 | 2022 | CURADEL LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 5 | NIH | 1/29/2024 | -$500 |
|
| Issue Date FY: 2023 ( Subtotal = -$13,837 ) |
| | 2023 | 2021 | CURADEL LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 5 | NIH | 9/19/2023 | -$3,522 |
| | 2023 | 2017 | CURADEL LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 4 | NIH | 10/1/2022 | -$10,316 |
|
| Issue Date FY: 2022 ( Subtotal = $808,023 ) |
| | 2022 | 2022 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 5 | NIH | 5/24/2022 | $808,023 |
|
| Issue Date FY: 2021 ( Subtotal = $2,342,505 ) |
| | 2021 | 2021 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 4 | NIH | 5/21/2021 | $1,595,693 |
| | 2021 | 2021 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 001 | 5 | NIH | 1/28/2021 | $37,342 |
| | 2021 | 2021 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 5 | NIH | 12/1/2020 | $709,470 |
|
| Issue Date FY: 2020 ( Subtotal = $2,340,855 ) |
| | 2020 | 2020 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 001 | 4 | NIH | 1/14/2020 | $74,515 |
| | 2020 | 2020 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 001 | 3 | NIH | 6/12/2020 | $1,595,693 |
| | 2020 | 2020 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 4 | NIH | 11/22/2019 | $670,647 |
| | 2020 | 2018 | CURADEL, LLC | 11 ERIE DR | NATICK | MA | 01760-1312 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 2 | NIH | 4/15/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $623,327 ) |
| | 2019 | 2019 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 3 | NIH | 12/17/2018 | $720,367 |
| | 2019 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 001 | 4 | NIH | 5/6/2019 | $0 |
| | 2019 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 4 | NIH | 4/25/2019 | $0 |
| | 2019 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01DE022820 | Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI | 000 | 5 | NIH | 2/3/2019 | $0 |
| | 2019 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 002 | 4 | NIH | 7/30/2019 | -$97,040 |
|
| Issue Date FY: 2018 ( Subtotal = $1,732,975 ) |
| | 2018 | 2018 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 2 | NIH | 11/21/2017 | $989,401 |
| | 2018 | 2018 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 001 | 2 | NIH | 5/23/2018 | $74,357 |
| | 2018 | 2018 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 2 | NIH | 11/28/2017 | $669,217 |
| | 2018 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 4 | NIH | 9/19/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $2,946,464 ) |
| | 2017 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R44CA210820 | ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping | 000 | 1 | NIH | 12/8/2016 | $989,401 |
| | 2017 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA207500 | Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS | 000 | 1 | NIH | 12/8/2016 | $767,586 |
| | 2017 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01DE022820 | Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI | 000 | 5 | NIH | 2/2/2017 | $494,189 |
| | 2017 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 4 | NIH | 9/13/2017 | $640,378 |
| | 2017 | 2017 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01DE022820 | Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI | 001 | 5 | NIH | 6/1/2017 | $54,910 |
| | 2017 | 2014 | CURADEL, LLC | 257 SIMARANO DR STE 100 | MARLBOROUGH | MA | 01752-3070 | MIDDLESEX | USA | R01CA115296 | Intraoperative Near-Infrared Fluorescence Imaging | 000 | 10 | NIH | 12/22/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,554,697 ) |
| | 2016 | 2016 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01DE022820 | Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI | 000 | 4 | NIH | 1/25/2016 | $549,099 |
| | 2016 | 2016 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 3 | NIH | 8/19/2016 | $1,005,598 |
|
| Issue Date FY: 2015 ( Subtotal = $1,777,466 ) |
| | 2015 | 2015 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01DE022820 | Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI | 000 | 3 | NIH | 3/5/2015 | $596,899 |
| | 2015 | 2015 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 001 | 2 | NIH | 8/28/2015 | $1,143,340 |
| | 2015 | 2014 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 1 | NIH | 12/22/2014 | $37,227 |
|
| Issue Date FY: 2014 ( Subtotal = $3,126,052 ) |
| | 2014 | 2014 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA115296 | Intraoperative Near-Infrared Fluorescence Imaging | 001 | 10 | NIH | 9/23/2014 | $1,709,724 |
| | 2014 | 2014 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 001 | 1 | NIH | 9/26/2014 | $143,400 |
| | 2014 | 2014 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01CA185457 | (PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment | 000 | 1 | NIH | 9/25/2014 | $901,396 |
| | 2014 | 2013 | CURADEL LLC | 377 PLANTATION STREET | WORCESTER | MA | 01605 | WORCESTER | USA | R01EB010022 | Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger | 001 | 5 | NIH | 8/7/2014 | $371,532 |
|
|
